Firebrick Pharma Ltd Cash Flow-to-Debt Ratio
Firebrick Pharma Ltd cash flow-to-debt ratio. Firebrick Pharma Ltd (FRE) has a Cash Flow-to-Debt Ratio of -3.08x as of December 2025, meaning its operating cash flow of AU$-1.05 Million could theoretically repay -3% of its total liabilities (AU$341.73K) in one year. See financial agility of Firebrick Pharma Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Firebrick Pharma Ltd (2019–2025)
Cash flow-to-debt ratio of Firebrick Pharma Ltd from 2019 to 2025. Historical debt coverage capacity for Firebrick Pharma Ltd across 7 annual periods. Also explore Firebrick Pharma Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Firebrick Pharma Ltd Cash Flow-to-Debt Ratio by Year (2019–2025)
Firebrick Pharma Ltd cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Firebrick Pharma Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Firebrick Pharma Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.56x | AU$-1.78 Million | AU$271.28K | ▲ +18.6% |
| 2024 | -8.06x | AU$-2.34 Million | AU$291.07K | ▲ +29.5% |
| 2023 | -11.42x | AU$-5.78 Million | AU$506.44K | ▼ -22.3% |
| 2022 | -9.34x | AU$-4.20 Million | AU$450.10K | ▼ -3.6% |
| 2021 | -9.01x | AU$-1.94 Million | AU$214.80K | ▼ -141.8% |
| 2020 | -3.73x | AU$-985.01K | AU$264.22K | ▲ +65.8% |
| 2019 | -10.91x | AU$-1.06 Million | AU$97.61K | — |